CLINICAL_TRIALS trial_result · 2020-11-24

Clinical Trial Update: EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for EN3835 in the treatment of edematous fibrosclerotic panniculopathy (cellulite) has completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

Snippet

Sponsor: Endo Pharmaceuticals | Conditions: Edematous Fibrosclerotic Panniculopathy, Cellulite | Phase 2 | Status: COMPLETED | Results posted: 2020-11-24